These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23793761)

  • 1. The role of methylation in urological tumours.
    van der Heijden AG
    Arch Esp Urol; 2013 Jun; 66(5):432-9. PubMed ID: 23793761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cytogenetic events in urologic tumors.
    Klein EA; Fair WR; Chaganti RS
    Semin Urol; 1988 Feb; 6(1):2-21. PubMed ID: 2838875
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumour suppressor genes in urinary tract oncology.
    Brewster SF; Gingell JC; Brown KW
    Br J Urol; 1992 Dec; 70(6):585-90. PubMed ID: 1336697
    [No Abstract]   [Full Text] [Related]  

  • 5. [Optimizing treatment of advanced urologic malignancies].
    Heidenreich A; Ohlmann CH; Ozgür E; Pfister D; Sahi D; Thüer D; Engelmann UH
    Urologe A; 2007 Sep; 46(9):1278-84. PubMed ID: 17628781
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylation profile of DNA repetitive elements in human testicular germ cell tumor.
    Ushida H; Kawakami T; Minami K; Chano T; Okabe H; Okada Y; Okamoto K
    Mol Carcinog; 2012 Sep; 51(9):711-22. PubMed ID: 21809391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation in urological malignancies (review).
    Schulz WA
    Int J Oncol; 1998 Jul; 13(1):151-67. PubMed ID: 9625817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?
    Netto GJ
    Adv Anat Pathol; 2013 May; 20(3):175-203. PubMed ID: 23574774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epigenome of testicular germ cell tumors.
    Lind GE; Skotheim RI; Lothe RA
    APMIS; 2007 Oct; 115(10):1147-60. PubMed ID: 18042148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epigenetic regulation of urological tumors. Importance for prognosis and metastasis].
    Heinzelmann J; Stubendorff B; Jung V; Baumgart S; Hölters S; Unteregger G; Grimm J; Linxweiler J; Janssen M; Ohlmann CH; Saar M; Siemer S; Stöckle M; Junker K
    Urologe A; 2015 Jun; 54(6):832-8. PubMed ID: 26037021
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
    Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1).
    Lind GE; Skotheim RI; Fraga MF; Abeler VM; Esteller M; Lothe RA
    J Pathol; 2006 Dec; 210(4):441-9. PubMed ID: 17029216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas.
    Florl AR; Löwer R; Schmitz-Dräger BJ; Schulz WA
    Br J Cancer; 1999 Jul; 80(9):1312-21. PubMed ID: 10424731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
    Phé V; Cussenot O; Rouprêt M
    BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
    Peng D; Ge G; Xu Z; Ma Q; Shi Y; Zhou Y; Gong Y; Xiong G; Zhang C; He S; He Z; Li X; Ci W; Zhou L
    Epigenomics; 2018 Sep; 10(9):1189-1199. PubMed ID: 30182734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic biomarkers in the blood of patients with urological malignancies.
    Ellinger J; Müller SC; Dietrich D
    Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.
    Duarte-Pereira S; Paiva F; Costa VL; Ramalho-Carvalho J; Savva-Bordalo J; Rodrigues A; Ribeiro FR; Silva VM; Oliveira J; Henrique R; Jerónimo C
    Eur J Cancer; 2011 May; 47(7):1106-14. PubMed ID: 21273058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of gene therapy in the treatment of urological tumors].
    Heidenreich A; von Knobloch R; Hofmann R
    Urologe A; 1999 Nov; 38(6):603-13. PubMed ID: 10591808
    [No Abstract]   [Full Text] [Related]  

  • 19. Epigenetics and testicular germ cell tumors.
    Buljubašić R; Buljubašić M; Bojanac AK; Ulamec M; Vlahović M; Ježek D; Bulić-Jakuš F; Sinčić N
    Gene; 2018 Jun; 661():22-33. PubMed ID: 29605605
    [No Abstract]   [Full Text] [Related]  

  • 20. Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.
    Morris MR; Hesson LB; Wagner KJ; Morgan NV; Astuti D; Lees RD; Cooper WN; Lee J; Gentle D; Macdonald F; Kishida T; Grundy R; Yao M; Latif F; Maher ER
    Oncogene; 2003 Oct; 22(43):6794-801. PubMed ID: 14555992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.